Tag Archives: SARSCoV2

Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine – nejm.org

Trial Population Table 1. Table 1. Demographic Characteristics of the Participants in the NVX-CoV2373 Trial at Enrollment. The trial was initiated on May 26, 2020; 134 participants underwent randomization between May 27 and June 6, 2020, including 3 participants who were to serve as backups for sentinel dosing and who immediately withdrew from the trial… Read More »

Cover-Up of SARS-CoV-2 Exposed

Read the Full Article for Free! You can unsubscribe at any time and I guarantee the privacy of your email. View our privacy policy Subscribe for FREE to the #1 Natural Health Newsletter or Login for Instant Access Unlock censored health information that Google doesn’t want you to read Keep your privacy secure — we… Read More »